Industrial BiotechSolar Foods starts Factory01Finnish Solar Foods Oy has started microbial production of its protein powder Solein in Factory 01, Solar Foods’ first commercial-scale production facility in Vantaa, Finland. more ➔
ApprovalShock: Adrenomed AG gets FDA fast track designationGerman AdrenoMed AG has got FDA Fast Track designation for its targeted septic shock medicine enibarcimab that restores endothel integrity. more ➔
CollaborationLonza AG enters R&D collaboration with NeuroSense Therapeutics LtdALS specialist NeuroSense Therapeutics Ltd announces it will be collaborating with Swiss Lonza AG to identify exosome-based biomarkers to advance theranostics in neurodegeneration. more ➔
NeurologyLonza AG enters R&D collaboration with NeuroSense Therapeutics LtdALS specialist NeuroSense Therapeutics Ltd announces it will be collaborating with Swiss Lonza AG to identify exosome-based biomarkers to advance theranostics in neurodegeneration. more ➔
AcquisitionEssential Pharma acquires Renaissance Pharma LtdEssential Pharma has acquired Renaissance Pharma Ltd to commercialise the company’s Phase II program Hu14.18K322A in pedriatric high-risk neuroblastoma. more ➔
MalariaUnitaid awards Medincell US$6m to fight malariaGlobal health agency Unitaid has awarded French Medincell Corp (Jacou) an extension grant of up to US$ 6 million over three years to fund thesatety testing of its malaria vaccine mdc-STM. more ➔
FinancingGenmab broadens ADC pipeline with $1.8bn acquisition of ProfoundBioGenmab announced today that it will acquire privately held biotech company ProfoundBio for $1.8bn in cash. The deal is designed to help the Danish pharmaceutical company deepen its cancer pipeline with … more ➔
CancerTME Pharma gets FDA Fast Track for Glioblastoma TME Pharma (France/Germany) announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for NOX-A12 (olaptesed pegol), TME Pharma’s CXCL12 inhibitor, in combination … more ➔
financingForbion participates in US financing rounds Forbion, the European life sciences venture capital firm from The Netherlands, announced its participation in oversubscribed Series B financing in Capstan Therapeutics Inc. and Engrail Therapeutics. … more ➔
Clinical trialsNew law to speed up clinical trialsWith a new law, the German government wants to increase the number of clinical trials conducted in Germany and make the country number one in Europe again. more ➔
